» Articles » PMID: 213391

Peritoneal Macrophage Activation Indicated by Enhanced Chemiluminescence

Overview
Journal Infect Immun
Date 1978 Sep 1
PMID 213391
Citations 19
Authors
Affiliations
Soon will be listed here.
Abstract

A number of studies have demonstrated the ability of various bacterial preparations, protozoa, and chemicals to activate macrophages and concomitantly to enhance host resistance to both tumors and infections. Recently, viral infections have been shown to have a similar effect upon macrophage function. To better define the metabolic state of activated macrophages, we have evaluated the ability of peritoneal cells (PC) from vaccinia virus- or murine cytomegalovirus-infected or Corynebacterium parvum-treated mice to emit chemiluminescence (CL) during phagocytosis of zymosan particles or yeasts. PC from C. parvum-treated mice (1,400 microgram intraperitoneally) emitted enhanced CL over controls on days 3, 6, 14, and 21 after treatment, thereby establishing the emission of CL as a correlate of metabolic activation. Previous evidence for activation of PC from vaccinia virus-infected mice (10(8) plaque-forming units) was confirmed by demonstration of enhanced levels of CL on days 3, 6, and 13 after murine infection. Likewise, PC from mice infected with murine cytomegalovirus (10(5) plaque-forming units) 3, 6, or 13 days previously demonstrated augmented levels of CL over controls. Opsonized virus particles (vaccinia virus or murine cytomegalovirus) failed to induce the emission of CL with PC from mice infected with the isologous virus. Our data further demonstrate the immunomodulationinduced by virus infections and suggest that the detection of CL is an easily quantitated correlate of macrophage activation which may be helpful in defining metabolic alterations induced during activation.

Citing Articles

Bioluminescence, chemiluminescence.

Dwenger A, Beychok C, Schweitzer G, Pape H, Rollig G, Nerlich M Fresenius J Anal Chem. 2020; 337(1):86-96.

PMID: 32226233 PMC: 7100654. DOI: 10.1007/BF00325727.


Opposite effects of Vaccinia and modified Vaccinia Ankara on trained immunity.

Blok B, Jensen K, Aaby P, Fomsgaard A, van Crevel R, Benn C Eur J Clin Microbiol Infect Dis. 2019; 38(3):449-456.

PMID: 30719592 DOI: 10.1007/s10096-018-03449-z.


Comparative Analysis of Microbicidal and Anti-inflammatory Properties of Novel Taurine Bromamine Derivatives and Bromamine T.

Walczewska M, Perun A, Bialecka A, Srottek M, Jamroz W, Dorozynski P Adv Exp Med Biol. 2017; 975 Pt 1:515-534.

PMID: 28849479 DOI: 10.1007/978-94-024-1079-2_41.


1-Methylnicotinamide and nicotinamide: two related anti-inflammatory agents that differentially affect the functions of activated macrophages.

Biedron R, Ciszek M, Tokarczyk M, Bobek M, Kurnyta M, Slominska E Arch Immunol Ther Exp (Warsz). 2008; 56(2):127-34.

PMID: 18373238 PMC: 2766500. DOI: 10.1007/s00005-008-0009-2.


Chemiluminescence, suppression and cytotoxicity in peripheral blood mononuclear cells from solid tumor cancer patients.

Braun D, De Boer K, Harris J Cancer Immunol Immunother. 1982; 14(2):86-91.

PMID: 6965231 PMC: 11041047. DOI: 10.1007/BF00200173.


References
1.
Jackson J . Supravital blood studies, using acridine orange fluorescence. Blood. 1961; 17:643-9. View

2.
Hemming V, Hall R, Rhodes P, Shigeoka A, Hill H . Assessment of group B streptococcal opsonins in human and rabbit serum by neutrophil chemiluminescence. J Clin Invest. 1976; 58(6):1379-87. PMC: 333309. DOI: 10.1172/JCI108593. View

3.
Scott M . Corynebacterium parvum as an immunotherapeutic anticancer agent. Semin Oncol. 1974; 1(4):367-78. View

4.
Glasgow L, Fischbach J, Bryant S, Kern E . Immunomodulation of host resistance to experimental viral infections in mice: effects of Corynebacterium acnes, Corynebacterium parvum, and Bacille calmette-guérin. J Infect Dis. 1977; 135(5):763-70. DOI: 10.1093/infdis/135.5.763. View

5.
Morahan P, Kern E, Glasgow L . Immunomodulator-induced resistance against herpes simplex virus. Proc Soc Exp Biol Med. 1977; 154(4):615-20. DOI: 10.3181/00379727-154-39730. View